March 21st 2024
GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.
Data Provide New Insights Into the When and How of Cervical Screenings
July 14th 2011Research has emerged validating and confirming the recommendations of the American Congress of Obstetricians and Gynecologists, the American Cancer Society, and the American Society for Colposcopy and Cervical Pathology to screen women for cervical cancer every 3 years if they have a negative human papillomavirus (HPV) test and a normal Pap test. However, the researchers also found that Pap testing was important among women who tested positive for HPV since it helped identify women who developed cancer or precancer.
Read More
Additional Links Ovarian Cancer Papillary Serous CystadenocarcinomaOvarian Papillary Cystadenocarcinoma"Krukenberg" tumor of ovaryCervical Cancer Stage I Cervical Squamous Cell CarcinomaCervical Squamous Cell CarcinomaExtensive Cervical Squamous Cell CarcinomaStage IV Cervical CarcinomaPelvic Exenteration for Cervical Squamous Cell Carcinoma
Read More
What Is the Role of Laparoscopic Surgery in Ovarian Cancer?
June 30th 2011Laparoscopic staging of apparent early ovarian cancer may be accomplished in patients where disease appears limited to the adnexa. For example a completely resected complex adnexal mass with intraoperative frozen-section revealing malignancy and no obvious limitation to complete laparoscopic staging.
Read More
The CISH technique (Classic Intrafascial Supracervical Hysterectomy)
June 23rd 2011The first carefully described abdominal supracervical hysterectomy was performed by Wilhelm Alexander Freund in 1878 and it was the leading technique for over 80 years. Tervilä described the danger of cervical cancer to be 0.3-1.9% following supracervical hysterectomy. Since 1950, hysterectomy has been performed almost exclusively as total hysterectomy, though since the 1990 interest in supracervical hysterectomy has been reawakened thanks to the introduction of Classic Intrafascial Supracervical Hysterectomy CISH) pelviscopic and laparotomy techniques .
Read More
For the past three decades, gynecologists have been utilizing the hysteroscope in the office to diagnose a variety of conditions that can be responsible for symptoms such as abnormal uterine bleeding, recurrent miscarriage, infertility, and post menopausal bleeding. The most common lesions found during diagnostic office hysteroscopy include cervical and uterine polyps, submucous myomata, uterine septae, intrauterine adhesions, endometrial hyperplasia and endometrial cancer.
Read More
Abnormal PAP Smears, HPV, Cervical Dysplasia and Cancer
June 21st 2011The terminology used to describe pap smear results has changed over the past few years, leading to confusion about what the results of your pap smear actually mean. Originally, pap smears were divided into 5 "classes" based on what the cells looked like to the pathologist. Class I was normal, while class II cells appeared a little irregular to the pathologist, usually representing bacterial infection. Class III and IV pap smears suggested that dysplastic cells were present, and further testing needed to be done. Class V usually meant cancer.
Read More
New Campaign Targets Fraudulent Products
June 15th 2011The FDA and the Federal Trade Commission (FTC) jointly launched the “Fraudulent STD Products Initiative.” This campaign targets over-the-counter (OTC) products sold online or in retail stores that claim to prevent, cure, or treat sexually transmitted diseases (STDs).
Read More
Assessment Tool Quantifies Risk for Ovarian Cancer
June 13th 2011More than half of the 600,000 hysterectomies performed in the 1900s involved bilateral salpingo-oophorectomy, and it has been estimated that many of those were performed solely to reduce the risk for ovarian cancer. While there has been increased knowledge in the risk in women with familial history, a knowledge gap still exists for other women, which could lead them down the path of potentially unnecessary surgery
Read More
Persistent infection with HPV is the principal cause of cervical cancer, with HPV implicated in more than 99% of cervical cancer cases worldwide.1 The cobas HPV (human papillomavirus) Test, recently approved by the FDA, identifies women at highest risk for the development of cervical cancer.
Read More
Poll: How often do you recommend the HPV vaccine?
May 28th 2011Dr Rebecca B. Perkins and colleagues recently found that the HPV vaccine was not being appropriately offered in a cohort of 136 young, low-income, minority women. The results of their study were presented at the Annual ACOG Meeting in Washington, DC.
Read More
Addressing Low HPV Vaccination Rates: Physicians May Need to Step-Up Recommendation Practices
May 26th 2011Considered to be one of the most common sexually transmitted infections, human papillomavirus (HPV) infection affects an estimated 26.8% of females aged 14 years to 59 years. This statistic includes low-risk HPV, which can cause genital warts and other nonmalignant conditions, as well as high-risk HPV, which can cause cervical cancer.
Read More
What Role Does Being Overweight Play in Endometrial Cancer?
April 18th 2011Endometrial cancer remains the most commonly diagnosed gynecologic cancer in the United States. In fact, the number of women affected by the disease continues to rise despite a slight decline in annual incidence rates in the past 30 years.
Read More
AACR: Human Papillomavirus Tied to Lung Cancer
April 15th 2011Several high-risk forms of human papillomavirus (HPV) antibodies may be associated with an increased risk of lung cancer, according to research presented at the annual meeting of the American Association for Cancer Research, held April 2 to 6 in Orlando, Fla.
Read More
Optical Coherence Tomography Identifies Cervical Cancer
April 15th 2011Optical coherence tomography (OCT), a new imaging technology that allows noninvasive cross-sectional imaging, has high sensitivity for diagnosing cervical cancer, but low specificity, according to a study published in the March issue of Lasers in Surgery and Medicine.
Read More
AACR: Diabetes Linked to Cancer Risk and Mortality
April 15th 2011Diabetes appears to be associated with a decreased risk of prostate cancer in men but an increased risk of other cancer types in both men and women, according to research presented at the annual meeting of the American Association for Cancer Research, held April 2 to 6 in Orlando, Fla.
Read More
Gynecologic Oncology: Is Robotic Laparoscopic Surgery a Valid, Safe Option?
April 11th 2011Performing surgeries laparoscopically offers patients faster recovery, decreased blood loss and transfusion rates, and less postoperative pain, but laparoscopic procedures in gynecologic oncology can be very challenging and requires significant technical expertise and experience. It is believed that the integration of robotics into these surgeries might offer a significant advantage in the learning curve, thus allowing more surgeons to offer this procedure to their patients. . . but is this an effective and safe alternative?
Read More
Uterine Risk Factors Impact Endometrial Cancer Survival
April 4th 2011Uterine risk factors (RF) strongly influence survival of women with endometrial cancer, independent of nodal metastasis, according to research published in the March issue of the American Journal of Obstetrics & Gynecology.
Read More
Number of Cancer Survivors in U.S. Reaches 11.7 Million
March 29th 2011The number of cancer survivors in the United States had increased to nearly 12 million by 2007, according to a report in the March 11 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Read More
Coding of Ovarian Cancer Diagnosis Delayed
March 29th 2011Free text contains extra information relating to the diagnosis of ovarian cancer, and in some cases indicates a time lag between the diagnosis and coding in the medical record, according to a study published online Feb. 23 in BMJ Open.
Read More
Cancer Patients Willing to Undergo Pre-Trial Testing
March 26th 2011Patients with advanced malignancies appear to be quite willing to undergo pharmacodynamic (PD) and pharmacokinetic (PK) tests in order to be enrolled in clinical trials, according to research published online Jan. 18 in Cancer.
Read More
Is Medicare Dangerous to Your Patient’s Health? If They Have Ovarian Cancer, Yes
March 15th 2011According to government estimates, the incidence of ovarian cancer is almost 13 per 100,000 women per year, and most cases are diagnosed in an advanced stage. As such, proper treatment is critical to ensure survival. However, Dr Melissa M. Thrall, fellow in the department of obstetrics and gynecology at the University of Washington, found that less than 40% of women reliant on Medicare receive standard care.
Read More
Understanding Referral Patterns for Ovarian Cancer
March 14th 2011Primary care physicians are the entry point for care for many patients. They are often responsible for determining when additional expertise is needed and to which specialist a patient should go for additional care. Although studies have shown that gynecologic oncologists can improve surgical and survival outcomes for patients with ovarian cancer, the referral rate from primary care physicians to gynecologic oncologists remains relatively low.
Read More